Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus

J Rheumatol. 1993 Oct;20(10):1679-83.

Abstract

Autoantibodies against the ribonucleoproteins B, B' and D are a serological marker of systemic lupus erythematosus (SLE). We mapped the epitopes recognized by autoantibodies on the SmD molecule by means of 7 synthetic peptides corresponding to the entire length of the protein. By ELISA assay, 25% of the lupus sera contained IgG antibodies specific for the C-terminal SmD sequence 95-119. This reactivity was confirmed by synthesizing the sequence as a multiple antigen peptide (MAP): antibodies reactive with the MAP 95-119 were present only in SLE and not in other connective tissue disorders. Sera containing high titers of anti-MAP 95-119 antibodies reacted in immunoblot with the SmD protein. These results indicate the presence of a dominant epitope in the C-terminal region of SmD, which is highly homologous to the Epstein-Barr virus induced nuclear protein EBNA I.

MeSH terms

  • Amino Acid Sequence
  • Antigens / immunology
  • Autoantibodies / analysis*
  • Autoantigens / genetics
  • Autoantigens / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes
  • Humans
  • Immunoblotting
  • Lupus Erythematosus, Systemic / immunology*
  • Molecular Sequence Data
  • Peptides / immunology
  • Ribonucleoproteins, Small Nuclear / immunology*
  • snRNP Core Proteins

Substances

  • Antigens
  • Autoantibodies
  • Autoantigens
  • Epitopes
  • Peptides
  • Ribonucleoproteins, Small Nuclear
  • snRNP Core Proteins